Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: BioNTech 0.114, CSL 3.6525.
* CSL reports semi-annually. Values are evenly split across both quarters within each half.
BioNTech vs CSL Net Worth and Market Cap
BioNTech (BNTX) and CSL (CSL.AX) are peers in Vaccines. BioNTech reported revenue of $114M as of Q2 2026, compared with $7.3B for CSL. CSL leads on revenue.
BioNTech's gross margin is 8.1% versus 44.4% for CSL. BioNTech's net margin is -777.3% versus -40.2% for CSL.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, BioNTech, CSL.| Metric | BioNTech | CSL |
|---|---|---|
| Market Cap | - | - |
| Revenue | $114.00M | $7.30B |
| Cost of Revenue | $105.00M | $4.06B |
| Gross Profit | $9.00M | $3.24B |
| Operating Income | $-1.02B | $1.39B |
| Net Income | $-886.00M | $-2.94B |
| R&D Expense | $595.00M | $614.00M |
| Earnings Per Share | -$3.5 | -$6.14 |
| Gross Margin | 8.1% | 44.4% |
| Operating Margin | -897.8% | 19.0% |
| Net Profit Margin | -777.3% | -40.2% |
| Free Cash Flow | $-48.00M | $1.76B |
| Cumulative Free Cash Flow | $19.56B | $21.56B |
| Operating Cash Flow | $12.00M | $2.09B |
| Cash & Equivalents | $10.52B | $1.51B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.